You just read:

NHL: Diffuse Large Bcell Lymphoma Epidemiology and Patient-Based Market 2016-2025 - New Targeted Therapies Across a Range of Treatment Settings Will Drive the Growth Market Despite Rituxan's Patent Expiry - Research and Markets

News provided by

Research and Markets

Aug 12, 2016, 09:10 ET